Clinical Trial Update: FDG PET-CT for Lymphoma Radiotherapy Planning Version 1.3 [NA]

View source ↗

Summary

This document updates a clinical trial evaluating FDG PET-CT for radiotherapy planning in lymphoma (version 1.3). The trial status is reported as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: The Leeds Teaching Hospitals NHS Trust | Conditions: Improve the Radiotherapy Planning Process | NA | Status: UNKNOWN